2
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Testing for human immunodeficiency virus

What to do if the result is positive

Pages 293-309 | Published online: 17 May 2016

References

  • Centers for Disease Control. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR 1987: 36(3): 509–15
  • Bayer R, Levine C, Wolf SM. HIV antibody screening: an ethical framework for evaluating proposed programs. JAMA 1986: 256(13): 1768–74
  • Henry K, Maki M, Crossley K. Analysis of the use of HIV antibody testing in a Minnesota hospital. JAMA 1988: 259(2): 229–32
  • Centers for Disease Control. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites. MMWR 1986: 35(17): 284–7
  • Petricciani JC. Licensed tests for antibody to human T-lymphotropic virus type III: sensitivity and specificity. Ann Intern Med 1985: 103: 726–9
  • Steckelberg JM, Cockerill FR 3d. Serologic testing for human immunodeficiency virus antibodies. Mayo Clin Proc 1988: 63(4): 373–80
  • Jackson JB, Balfour HH Jr. Practical diagnostic testing for human immunodeficiency virus. Clin Microbiol Rev 1988: 1(1): 124–38
  • Sivak SL, Wormser GP. Predictive value of a Screening test for antibodies to HTLV-III. Am J Clin Pathol 1986: 85(6): 700–3
  • Burke DS, Redfield RR. False-positive Western blot tests for antibodies to HTLV-III. (Letter) JAMA 1986: 256(3): 347
  • Mayer KH, Falk LA, Paul DA, et al. Correlation of enzyme-linked immunosorbent assays for serum HIV antigen and antibodies to recombinant viral proteins with subsequent clinical outcomes in a cohort of asymptomatic homosexual men. Am J Med 1987: 83(Aug): 208–12
  • Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 1986: 35(20): 334–9
  • Moss AR, Bacchetti P, Osmond D, et al. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J 1988: 296(Mar 12): 745–9
  • Goodman DS, Teplitz ED, Wishner A, et al. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol 1987: 17(Aug): 210–20
  • McArthur JC. Neurologic manifestations of AIDS. Medicine 1987: 66(6): 407–37
  • Laurence J. HIV associated hematologic disorders. Infect Med 1987(Jan): 9–11, 15–7
  • Groopman JE. Neoplasms in the acquired immune deficiency syndrome: the multidisciplinary approach to treatment. Semin Oncol 1987: 14(2 Suppl 3): 1–6
  • Mindel A. Management of early HIV infection. Br Med J 1987: 294(May 9): 1214–8
  • Glatt AE, Chirgwin K, Landesman SH. Treatment of infections associated with human immunodeficiency virus. N Engl J Med 1988: 318(22): 1439–48
  • Marzuk PM, Tierney H, Tardiff K, et al. Increased risk of suicide in persons with AIDS. JAMA 1988: 259(9): 1333–7
  • Richman DD, Fischl MA, Grleco MH, et al. The toxicity of azidothymidlne (AZT) in the treatment of patients with AIDS or AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987: 317(Jul 23): 192–7
  • Azidothymidine for AIDS. Med Lett Drugs Ther 1986: 28(726): 107–9
  • Yarchoan R, Bioder S. Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders: a progress report. N Engl J Med 1987: 316(9): 557–63

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.